Inozyme Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Net Income	-	229,908	197,612	158,893	140,148	117,478	Upgrade
Depreciation & Amortization	-	552.3	522.6	490.3	317.8	224.4	Upgrade
Other Amortization	-	4.6	11.3	27.5	30	30.1	Upgrade
Loss (Gain) From Sale of Investments	-	1,430	-86.2	872.8	56,951	59,434	Upgrade
Asset Writedown & Restructuring Costs	-	-5,904	-3,530	-1,047	-3,441	-235.9	Upgrade
Provision for Credit Losses	-	13,357	-15,422	-2,411	-	-	Upgrade
Loss (Gain) on Equity Investments	-	2.5	1.8	-0.1	224	-62.4	Upgrade
Change in Other Net Operating Assets	-	-1,238,784	-1,221,341	-1,010,910	-209,320	-811,570	Upgrade
Other Operating Activities	-	76,800	64,041	106,952	64,341	43,276	Upgrade
Operating Cash Flow	-	-922,694	-978,204	-747,172	49,045	-591,426	Upgrade
Capital Expenditures	-	-8,435	-3,239	-1,228	-3,061	-1,148	Upgrade
Sale of Property, Plant & Equipment	-	60.7	19.6	49.2	317.2	9.7	Upgrade
Investment in Securities	-	-14,746	-30,870	-15,757	-2,730	18,549	Upgrade
Investing Cash Flow	-	-23,120	-34,090	-16,936	-5,474	17,411	Upgrade
Short-Term Debt Issued	-	59,873	-	-	-	62,713	Upgrade
Long-Term Debt Issued	-	1,055,087	1,107,058	797,028	420,362	567,377	Upgrade
Total Debt Issued	-	1,114,959	1,107,058	797,028	420,362	630,090	Upgrade
Short-Term Debt Repaid	-	-	-1,356	-	-123,648	-	Upgrade
Long-Term Debt Repaid	-	-91,495	-31,130	-29.4	-334,897	-7.3	Upgrade
Total Debt Repaid	-	-91,495	-32,486	-29.4	-458,545	-7.3	Upgrade
Net Debt Issued (Repaid)	-	1,023,464	1,074,572	796,998	-38,183	630,083	Upgrade
Issuance of Common Stock	-	1,000	-	-	-	5,575	Upgrade
Common Dividends Paid	-	-81,885	-61,951	-41,626	-45,539	-31,421	Upgrade
Other Financing Activities	-	-	-7.8	-7.1	15.6	4.2	Upgrade
Financing Cash Flow	-	942,579	1,012,613	755,366	-83,706	604,241	Upgrade
Net Cash Flow	-	-3,235	319	-8,742	-40,135	30,225	Upgrade
Free Cash Flow	-	-931,129	-981,444	-748,400	45,984	-592,574	Upgrade
Free Cash Flow Margin	-	-213.92%	-264.52%	-224.25%	16.42%	-264.97%	Upgrade
Free Cash Flow Per Share	-	-282.15	-297.40	-226.78	13.93	-179.56	Upgrade
Cash Income Tax Paid	-	78,335	63,659	50,990	53,413	50,752	Upgrade

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.